
|Articles|December 1, 2004
Accommodating lens available in 0.25-D steps
Aliso Viejo, CA-The FDA has given Eyeonics Inc. approval to market its Crystalens accommodating IOL in quarter-diopter steps. The approval makes eyeonics the first U.S. company to launch 0.25-D IOLs, the company said. The lenses were made available Nov. 1 to credentialed Crystalens surgeons.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
AAO 2025: Glaucoma laser surgery with Joel S. Schuman, MD, FACS
3
News from Orlando: AAO 2025 highlights research across all areas of eyecare
4
AAO 2025: Clinical outcomes of early vs delayed pegcetacoplan treatment in GA
5